Pharmacogenomics Testing
THE USE OF PHARMACOGENOMICS TESTING TO ESTABLISH THE CORRECT DRUG/DOSES THAT ARE INDIVIDUALIZED FOR EACH PATIENT, CAN DRAMATICALLY IMPROVE PATIENT COMPLIANCE AND POTENTIALLY DECREASE ADVERSE EVENTS.
CARDIOVASCULAR HEALTH
Our cardiovascular profile helps determine the risk of thrombosis or prothrombin deficiency. It also helps determine the therapeutic value of commonly used drugs for cardiovascular conditions.
PAIN MANAGEMENT
Our cardiovascular profile helps determine the risk of thrombosis or prothrombin deficiency. It also helps determine the therapeutic value of commonly used drugs for cardiovascular conditions.
MENTAL HEALTH
Our cardiovascular profile helps determine the risk of thrombosis or prothrombin deficiency. It also helps determine the therapeutic value of commonly used drugs for cardiovascular conditions.
Research shows...
that adherent patients have a shorter duration of treatment and better outcomes, resulting in a decreased overall cost of care. Those who are stratified to receive pharmacogenomic testing often have a better and more cost-effective outcome.
CARDIOVASCULAR HEALTH
MENTAL HEALTH
30 psychotropics required by FDA to include genetic information, dosage and administration, warnings and precautions, drug interactions, clinical pharmacology, contraindications, and adverse drug reactions.
Why Perform Genetic Testing?
1. Medication Safety Basics. Centers for Disease Control and Prevention Medication Safety Program.
2. Carlson B. Declaring War on Warfarin Misdosing. Biotechnol Health.
3. Fanikos, John, et al. Major bleeding complications in a specialized anticoagulation service.
4. Emmerich J, et al. “Compound effect of Factor V and prothrombin 20120A”.
5. Why antidepressants Don’t Work for Half of Patients, http://www.livescience.com
Kingdom Health Laboratory
PH 469.995.7877 · KingdomHealthlab.com